Sagimet Biosciences (SGMT) Return on Sales (2023 - 2024)
Sagimet Biosciences has reported Return on Sales over the past 2 years, most recently at 14.63% for Q2 2024.
- Quarterly results put Return on Sales at 14.63% for Q2 2024, changed N/A from a year ago — trailing twelve months through Jun 2024 was 14.63% (changed N/A YoY), and the annual figure for FY2023 was 13.94%, changed.
- Return on Sales for Q2 2024 was 14.63% at Sagimet Biosciences, down from 13.96% in the prior quarter.
- Over the last five years, Return on Sales for SGMT hit a ceiling of 3.18% in Q3 2023 and a floor of 14.63% in Q2 2024.